Aug 01, 2019 XOMA Congratulates Rezolute on its Successful Financing and Progress Towards Initiating Phase 2b Study for RZ358
Jun 07, 2019 XOMA Congratulates Iscalimab Anti-CD40 Antibody Development Program on its Early Clinical Successes
Sep 3, 2019 • 8:00 AM EDT XOMA to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Aug 6, 2019 • 7:30 AM EDT XOMA Reports Second Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results
Recent Event Sep 10, 2019 • 10:00 am EDT H.C. Wainwright 21st Annual Global Investment Conference View Event View All
